GlassScriptPhysician profile
Anthony R Lim
NPI 1093804932
$1,732.26
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,634 · 2024: $98.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $223.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $217.86 | 2019-2024 | Imfinzi |
| Astellas Pharma US INC | $194.44 | 2019 | |
| Merck Sharp & Dohme LLC | $172.35 | 2019 | |
| Amgen INC. | $150.93 | 2019 | |
| Pfizer INC. | $139.82 | 2019 | |
| Janssen Biotech, INC. | $123.42 | 2019 | |
| Lilly USA, LLC | $110.68 | 2019 | |
| Celgene Corporation | $67.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $64.47 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.66 | 2019 | |
| Abbvie INC. | $43.02 | 2019-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $40.33 | 2019 | |
| Array Biopharma INC | $32.13 | 2019 | |
| Verastem, INC. | $24.02 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $22.66 | 2019 | |
| Eisai INC. | $21.43 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $20.78 | 2019 | |
| Puma Biotechnology, INC. | $18.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.